A multidisciplinary team of scientists led by University of Helsinki reports that a progressive neurodegenerative disease can be triggered by a viral infection. The mechanism relates to mitochondrial roles in antiviral defense ...
Apr 4, 2024
0
27
With new cases, hospitalizations and mortality rates holding steady in many parts of the world, University of Georgia researchers have developed a faster detection technique for COVID-19.
Apr 4, 2024
0
61
The A*STAR Infectious Diseases Labs (A*STAR ID Labs) and the Hackensack Meridian Health Center for Discovery and Innovation have teamed up to shed light on a concerning health issue—infections caused by a type of bacteria ...
Apr 2, 2024
0
21
Researchers from Rutgers believe they are among the leaders in a race to find an oral COVID-19 treatment to supplement or replace Paxlovid—an antiviral medication that helps keep high-risk patients out of the hospital.
Mar 28, 2024
0
1
Roughly 25,000 Americans die each year from valvular heart disease, but researchers from Rutgers Health and other institutions conclude that new technology could soon help doctors slash that number.
Mar 28, 2024
0
0
Mild cognitive impairment—an early stage of dementia—is widely underdiagnosed in people 65 and older. That is the key takeaway of two recent studies from our team.
Mar 24, 2024
0
408
Using novel genetic and genomic tools, researchers at the Icahn School of Medicine at Mount Sinai have shed light on the role of immune cells called macrophages in lipid-rich tissues like the brain, advancing our understanding ...
Mar 21, 2024
0
46
Malnutrition may increase a person's chances of contracting Alzheimer's disease, which in turn exacerbates malnutrition. That's according to a March 2024 study out of China published in Frontiers in Nutrition.
Mar 20, 2024
0
1
A novel approach in the field of Alzheimer's research is emerging that could potentially transform how we tackle this debilitating disease. Recent studies have revealed a paradigm shift in understanding Alzheimer's pathology, ...
Mar 19, 2024
0
20
A research team led by the University of California, Irvine has discovered the key role that the APOBEC3A and APOBEC3B enzymes play in driving cancer mutations by modifying the DNA in tumor genomes, offering potential new ...
Mar 19, 2024
0
60
